Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis

摘要

Background The role of neutrophil gelatinase-associated lipocalin (NGAL) as a diagnostic marker for acute kidney injury (AKI) in sepsis is still debated. We hypothesized that in sepsis, the performance of serum(s) and urinary(u) NGAL can be negatively impacted by severity of illness and inflammation, and that both uNGAL and sNGAL levels can be increased regardless of presence of AKI. Methods One hundred and seven patients with sepsis were included. uNGAL and sNGAL were measured at admission (T0) and 4?hours (T4) and 24?hours later (T24). Transient and intrinsic AKI were respectively defined as AKI according to RIFLE during the first 72?hours that did or did not recover to “no AKI” in the following 72?hours. Patients were classified according to tertiles of CRP and APACHE II score increase. The relationship between sNGAL and uNGAL was assessed by linear regression. Results Fifty-seven patients developed transient and 22 intrinsic AKI. Prevalence of transient and intrinsic AKI were higher in patients with versus without septic shock (OR (95% CI):3.3(1.4-8.2)). uNGAL was associated with sNGAL, and this with parallel slopes but different intercepts for AKI (Y?=?0.87*X?+?314.3,R2?=?0.31) and no AKI (Y?=?0.87*X?+?20.1,R2?=?0.38). At T4, median uNGAL and sNGAL levels were higher in septic patients with versus without shock but this is independent of AKI ((545?ng/mL vs 196?ng/ml for uNGAL and 474?ng/ml vs 287?ng/ml for sNGAL (both P?=?0.003)). Both uNGAL and sNGAL levels increased with tertiles of CRP and APACHE II score increase. Conclusions Serum and uNGAL levels are influenced by severity of illness and inflammation, and this was found to be independent of the presence of AKI. There is a strong correlation between sNGAL and uNGAL levels in patients with sepsis, indicating that increased levels of uNGAL can also be due to overspill from the systemic circulation, blurring the discriminative value of NGAL as a biomarker for AKI in patients with sepsis.